+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Liver And Kidney Disorders Drugs Market Research Reports

Lupus Nephritis - Epidemiology Forecast - 2032 - Product Thumbnail Image

Lupus Nephritis - Epidemiology Forecast - 2032

  • Report
  • January 2024
  • 84 Pages
  • Global
From
Chronic Hepatitis B - Market Insight, Epidemiology And Market Forecast - 2032 - Product Thumbnail Image

Chronic Hepatitis B - Market Insight, Epidemiology And Market Forecast - 2032

  • Report
  • November 2023
  • 262 Pages
  • Global
From
IgA Nephropathy (IgAN) - Epidemiology Forecast - 2032 - Product Thumbnail Image

IgA Nephropathy (IgAN) - Epidemiology Forecast - 2032

  • Report
  • July 2023
  • 100 Pages
  • Global
From
Chronic Kidney Disease - Competitive landscape, 2023 - Product Thumbnail Image

Chronic Kidney Disease - Competitive landscape, 2023

  • Report
  • April 2023
  • 190 Pages
  • Global
From
Chronic Kidney Disease - Market Insight, Epidemiology And Market Forecast - 2032 - Product Thumbnail Image

Chronic Kidney Disease - Market Insight, Epidemiology And Market Forecast - 2032

  • Report
  • April 2023
  • 246 Pages
  • Global
From
Primary Biliary Cholangitis - Epidemiology Forecast - 2032 - Product Thumbnail Image

Primary Biliary Cholangitis - Epidemiology Forecast - 2032

  • Report
  • February 2023
  • 97 Pages
  • Global
From
Primary Biliary Cholangitis - Market Insight, Epidemiology And Market Forecast - 2032 - Product Thumbnail Image

Primary Biliary Cholangitis - Market Insight, Epidemiology And Market Forecast - 2032

  • Report
  • February 2023
  • 195 Pages
  • Global
From
Primary Sclerosing Cholangitis - Epidemiology Forecast - 2032 - Product Thumbnail Image

Primary Sclerosing Cholangitis - Epidemiology Forecast - 2032

  • Report
  • August 2022
  • 91 Pages
  • Global
From
Liver Fibrosis - Market Insight, Epidemiology And Market Forecast - 2032 - Product Thumbnail Image

Liver Fibrosis - Market Insight, Epidemiology And Market Forecast - 2032

  • Report
  • August 2022
  • 239 Pages
  • Global
From
Liver Fibrosis - Epidemiology Forecast - 2032 - Product Thumbnail Image

Liver Fibrosis - Epidemiology Forecast - 2032

  • Report
  • August 2022
  • 119 Pages
  • Global
From
Autosomal Dominant Polycystic Kidney Disease - Market Insight, Epidemiology and Market Forecast - 2032 - Product Thumbnail Image

Autosomal Dominant Polycystic Kidney Disease - Market Insight, Epidemiology and Market Forecast - 2032

  • Report
  • July 2022
  • 146 Pages
  • Global
From
Autosomal Dominant Polycystic Kidney Disease - Epidemiology Forecast - 2032 - Product Thumbnail Image

Autosomal Dominant Polycystic Kidney Disease - Epidemiology Forecast - 2032

  • Report
  • July 2022
  • 73 Pages
  • Global
From
Primary Hyperoxaluria - Market Insight, Epidemiology and Market Forecast - 2032 - Product Thumbnail Image

Primary Hyperoxaluria - Market Insight, Epidemiology and Market Forecast - 2032

  • Report
  • February 2022
  • 152 Pages
  • Global
From
Primary Hyperoxaluria - Epidemiology Forecast - 2032 - Product Thumbnail Image

Primary Hyperoxaluria - Epidemiology Forecast - 2032

  • Drug Pipelines
  • February 2022
  • 76 Pages
  • Global
From
Chronic Kidney Disease - Epidemiology Forecast to 2032 - Product Thumbnail Image

Chronic Kidney Disease - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Familial Chylomicronemia Syndrome (FCS) - Market Insight, Epidemiology and Market Forecast -2032 - Product Thumbnail Image

Familial Chylomicronemia Syndrome (FCS) - Market Insight, Epidemiology and Market Forecast -2032

  • Report
  • January 2022
  • 200 Pages
  • Global
From
Biliary Atresia (BA) - Epidemiology Forecast - 2032 - Product Thumbnail Image

Biliary Atresia (BA) - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Homocystinuria - Epidemiology Insight - 2032 - Product Thumbnail Image

Homocystinuria - Epidemiology Insight - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Acute On Chronic Liver Failure (ACLF) - Epidemiology Forecast to 2032 - Product Thumbnail Image

Acute On Chronic Liver Failure (ACLF) - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Hepatorenal Syndrome (HRS) - Epidemiology Forecast to 2032 - Product Thumbnail Image

Hepatorenal Syndrome (HRS) - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Loading Indicator

The Liver and Kidney Disorders Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs to treat diseases and disorders of the liver and kidneys. These drugs are used to treat a variety of conditions, including hepatitis, cirrhosis, kidney failure, and other kidney-related diseases. The market is highly competitive, with many companies vying for market share. The market is driven by the increasing prevalence of liver and kidney diseases, as well as the development of new treatments and technologies. Additionally, the rising demand for better treatments and the increasing availability of generic drugs are also contributing to the growth of the market. Some of the major companies in the Liver and Kidney Disorders Drugs market include Pfizer, Merck, Novartis, Sanofi, GlaxoSmithKline, AstraZeneca, Bristol-Myers Squibb, and AbbVie. These companies are engaged in the development and production of drugs to treat liver and kidney diseases. Show Less Read more